SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus

Biochemical and Biophysical Research Communications

Volumn 286, Issue 3, 2001, Pages 559-565

  Imoto, Issei ^a   Pimkhaokham, Atiphan ^a   Fukuda, Yoji ^a   Yang, Zeng Quan ^a   Shimada, Yutaka ^b   Nomura, Nobuo ^c   Hirai, Hisamaru ^d   Imamura, Masayuki ^b   Inazawa, Johji ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KAZUSA DNA RESEARCH INSTITUTE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

3q26; Amplification; Esophageal squamous cell carcinoma; EVI1; PIK3CA; SNO; TERC

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; ESOPHAGUS CARCINOMA; GENE; GENE AMPLIFICATION; GENE LOCUS; GENE SNO; GENE TARGETING; GENETIC CODE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

EID: 0034807364     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.5428     Document Type: Article

References (44)

1. Oncogene amplification in solid tumors
2. Amplification of the EGF receptor and c-myc genes in human esophageal cancers
3. Amplification and expression of the human cyclin D gene in esophageal cancer
4. Comparative genomic hybridization of squamous cell carcinoma of the esophagus: The possible involvement of the DP1 gene in the 13q34 amplicon
5. Molecular cytogenetic fingerprinting of esophageal squamous cell carcinoma by comparative genomic hybridization reveals a consistent pattern of chromosomal alterations
6. Nonrandom chromosomal imbalances in esophageal squamous cell carcinoma cell lines: Possible involvement of the ATF3 and CENPF genes in the 1q32 amplicon
7. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix
8. Molecular definition of a small amplification domain within 3q26 in tumors of cervix, ovary, and lung
9. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas
10. Amplification of the genes BCHE and SLC2A2 in 40% of squamous cell carcinoma of the lung
11. Expression analysis of genes at 3q26-q27 involved in frequent amplification in squamous cell lung carcinoma
12. Comparative genomic hybridization analysis detects frequent over-representation of DNA sequences at 3q, 7p, and 8q in head and neck carcinomas
13. Novel amplification unit at chromosome 3q25-q27 in human prostate cancer
14. PIK3CA as an oncogene in cervical cancer
15. Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer
16. PIK3CA is implicated as an oncogene in ovarian cancer
17. MDS1/EVI1 enhances TGF-beta1 signaling and strengthens its growth-inhibitory effect but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-beta1
18. SnoN and ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling
19. Role of transforming growth factor b in human disease
20. TGF-beta signaling and cancer: Structural and functional consequences of mutations in Smads
21. TGF-beta signal transduction
22. Frequency of Smad gene mutations in human cancers
23. Mutation analysis of transforming growth factor beta type II receptor, Smad2, Smad3 and Smad4 in esophageal squamous cell carcinoma
24. A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma
25. Characterization of 21 newly established esophageal cancer cell lines
26. Physical ordering of three polymorphic DNA markers spanning the regions containing a tumor suppressor gene of renal cell carcinoma by three-color fluorescent in situ hybridization
27. Clonal origin of Philadelphia chromosome negative cells with trisomy 8 appearing during the course of alpha-interferon therapy for Ph positive chronic myelocytic leukemia
28. Identification of a novel gene, GASC1, within an amplicon at 9p23-24 frequently detected in esophageal cancer cell lines
29. Isolation of human cDNA clones of ski and the ski-related gene, SNO
30. Genomic sequencing of DPC4 in the analysis of familial pancreatic carcinoma
31. The human caspase-activated DNase (CAD) gene: Genomic structure, exonic single-nucleotide polymorphisms, and a highly polymorphic dinucleotide repeat at the CAD locus
32. The human homologue for the Caenorhabditis elegans cul-4 gene is amplified and overexpressed in primary breast cancers
33. Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26
34. DNA rearrangements proximal to the EVI1 locus associated with the 3q21q26 syndrome
35. Structurally altered EVI1 protein generated in the 3q21q26 syndrome
36. The oncoprotein EVI1 represses TGF-beta signalling by inhibiting Smad3
37. The t(3;21) fusion product, AML1/EVI1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells
38. Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein
39. Signaling inputs coverage on nuclear effectors in TGF-β signaling
40. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability
41. MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma
42. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
43. DPC4 gene in various tumor types
44. Sequence and biological activity of chicken SnoN cDNA clones